Leukocytosis Diagnosis and Management

Type 1: Reactive Leukocytosis

Adult-Onset Still's Disease commonly presents with marked neutrophilic leukocytosis, with 50% of patients having WBC >15,000/μL and 37% exceeding 20,000/μL, according to the American College of Rheumatology 1
Chronic inflammatory conditions cause persistent leukocytosis through ongoing bone marrow granulocyte hyperplasia, as stated by the European League Against Rheumatism 1
Connective tissue diseases and autoimmune disorders can cause leukocytosis, as reported by the American College of Rheumatology 2, 1
Iron deficiency, splenectomy, surgery, metastatic cancer, and lymphoproliferative disorders can also cause reactive leukocytosis, according to the American Society of Hematology 3, 2

Acute myeloid leukemia (AML) can present with hyperleukocytosis (WBC >100,000/μL), constituting a medical emergency due to risk of hemorrhagic events, tumor lysis syndrome, and leukostasis, as stated by the National Comprehensive Cancer Network 1
Chronic lymphocytic leukemia (CLL) presents with progressive lymphocytosis, with increases >50% over 2 months or lymphocyte doubling time <6 months, according to the International Workshop on Chronic Lymphocytic Leukemia 1
Chronic myelogenous leukemia (CML) is characterized by BCR-ABL1 fusion gene, as reported by the National Cancer Institute 4, 2
Polycythemia vera demonstrates JAK2 V617F mutation in >90% of cases, with trilineage proliferation, according to the European Hematology Association 2, 5
Essential thrombocythemia shows sustained platelet count ≥450 × 10⁹/L with megakaryocytic proliferation, as stated by the International Working Group for Myeloproliferative Neoplasms 4, 2
Primary myelofibrosis presents with megakaryocyte proliferation and atypia, often with JAK2 V617F or MPL mutations, according to the World Health Organization 4, 2

The presence of clonal markers (JAK2 V617F, BCR-ABL1, MPL mutations) is a red flag for primary (malignant) leukocytosis, as reported by the American Society of Hematology 4, 2, 6
Hyperleukocytosis (WBC >100,000/μL) is a medical emergency requiring immediate aggressive hydration and consideration of cytoreduction with hydroxyurea, according to the American College of Emergency Physicians 1, 7

Adult‑Onset Still’s disease frequently produces a pronounced neutrophilic leukocytosis (about half of patients show markedly raised white‑blood‑cell counts, and more than one‑third have very high levels) together with reactive thrombocytosis, reflecting a chronic cytokine‑driven marrow response. 8

In secondary thrombocytosis, inflammatory markers such as erythrocyte‑sedimentation rate and fibrinogen are typically elevated, and thrombotic complications are confined to the venous circulation and occur only when additional pro‑thrombotic risk factors are present. 8

When platelet counts become extremely high (on the order of 1,000 × 10⁹/L), there is a paradoxical risk of both thrombosis and acquired von Willebrand disease, which can lead to bleeding complications if not recognized. 8

The presence of leukocytosis at the time of diagnosis of polycythemia vera or essential thrombocythemia is linked to a higher incidence of both thrombotic events and major hemorrhage, especially in younger adults (under 60 years of age). 9